Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPASS: Intranasal Sumatriptan vs Tablets in Acute Migraine
NCT01667679Phase 3Completed
- Sponsor
- Avanir Pharmaceuticals
- Start
- Aug 2012
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sumatriptan in migraine, sponsored by Avanir Pharmaceuticals. Started Aug 2012; status: completed.
02
Drugs
sumatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT01667679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01667679.